Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02513641 · ClinicalTrials.gov registry record · NA
Effect of 2-Week Nightly Moderate Hypoxia on Glucose Tolerance in Individuals With Type 2 Diabetes
A NA study, sponsored by Pennington Biomedical Research Center.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT02513641 is a NA study that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 8 participants.
The verdict
NCT02513641, a NA study, has completed, sponsored by Pennington Biomedical Research Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if 2 weeks of nightly exposure (7-12 hours per night) to moderate hypoxia (\~2,400 meters or 7,500 feet) improves glucose metabolism in people with type 2 diabetes.
Interventions
- DEVICE Hypoxico Altitude Training Systems
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2015-12 |
| Est. Completion | 2020-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02513641
The ClinicalTrials.gov registry entry for NCT02513641 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pennington Biomedical Research Center, which has 258 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Hypoxico Altitude Training Systems is the first listed.
NCT02513641 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02513641 about?
NCT02513641 is a clinical study titled "Effect of 2-Week Nightly Moderate Hypoxia on Glucose Tolerance in Individuals With Type 2 Diabetes". The purpose of this study is to determine if 2 weeks of nightly exposure (7-12 hours per night) to moderate hypoxia (\~2,400 meters or 7,500 feet) improves glucose metabolism in people with type 2 diabetes.
What is the current status of trial NCT02513641?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2015-12. Estimated completion is 2020-09.
What interventions are being tested in trial NCT02513641?
The interventions under investigation include: Hypoxico Altitude Training Systems (DEVICE).
Who is sponsoring clinical trial NCT02513641?
This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.